Novacyt S.A.
Novacyt S.A. (PAR: ALNOV) is trading at €0.51, about ₹56 at today's EUR/INR rate, as of 25 Sep 2026, 10:14 AM ET, up 0.99% today. Indian residents can buy Novacyt from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€0.50
Today's high
€0.53
52 week low
€0.29
52 week high
€1.04
ALNOV opened at €0.51, closed previously at €0.51, and has traded between €0.29 and €1.04 over the past 52 weeks.
About
Founded in 2006 and headquartered in Vélizy-Villacoublay, France, Novacyt S.A. and its subsidiaries are actively involved in the full lifecycle of diagnostic products, encompassing development, manufacturing, custom design, and global commercialization. These vital diagnostic tools are employed in the detection of both cancer and a variety of infectious diseases. The company boasts an extensive international reach, serving markets throughout the United Kingdom, wider Europe, the United States, the Asia Pacific region, the Middle East, and Africa. Novacyt's operations are structured around three core segments. Primer Design specializes in the creation, production, and sale of molecular real-time qPCR testing devices and reagents, primarily for infectious disease diagnostics. Lab21 Products focuses on developing, manufacturing, and distributing a diverse portfolio of protein-based in-vitro diagnostic (IVD) products, also targeting infectious diseases. The IT-IS International segment is dedicated to engineering and fabricating PCR instruments used in the life sciences and food testing industries. The company's clientele principally includes hospitals and various corporate organizations.
Key statistics
Avg. volume
953.30K
Market cap
€36.98M
P/E Ratio
-0.96
Price-to-sales ratio
1.26
Enterprise value
£23.14M
Free cash flow yield
-34.33%
Debt-to-equity ratio
0.45
Return on equity
-96.46%
ROIC
-32.01%
Beta
1.12
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
£20.40M
Earnings per share
-£0.33
Free cash flow
-£9.03M
Net profit margin
-123.91%
Gross margin
49.82%
EBITDA
-£8.21M
Revenue growth
3.94%
Similar securities
This is not an investment recommendation
How to buy Novacyt from India
Indian residents can buy Novacyt shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Novacyt and place an order
Find Novacyt by name or by its ticker, ALNOV, and choose an order type. Novacyt trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Novacyt position in EUR and INR. Novacyt pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Novacyt from India
Trading and taxes when buying Novacyt from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneNovacyt does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Novacyt stock?
Yes. Novacyt (ALNOV) has been listed on Euronext Paris since 2012, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Novacyt share cost in rupees?
One Novacyt share is €0.51 — about ₹56 at an EUR/INR rate of 109.24 on 24 Sep 2026. Both the Novacyt price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Novacyt from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Novacyt shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Novacyt price. Paasa issues a capital-gains statement for your return.
Does Novacyt pay a dividend?
No. Novacyt does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Novacyt from India?
Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.
Do I have to declare Novacyt shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Novacyt holding, its cost and its closing value.
How do I sell Novacyt and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Novacyt?
Yes. Novacyt is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.